Best Practice & Research Clinical Rheumatology
Volume 21, Issue 6 , Pages 1011-1023 , December 2007

Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology

  • Marta Mosca, MD (Assistant Professor in Rheumatology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Via Roma 67, 56126 Pisa, Italy.
    • ,
  • Chiara Tani, MD (Research fellow in Rheumatology)
    • ,
  • Stefano Bombardieri, MD (Professor in Rheumatology)

References 

  1. Lockshin MD. What is SLE? Editorial. The Journal of Rheumatology. 1989;16:419–420
  2. LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis & Rheumatism. 1980;23:341–343
  3. Moutsopoulos HM, Talal N. Viewpoint. Connective tissue diseases: one disease or many?. Lupus. 1994;3:5–10
  4. Wigley FM. When is scleroderma really scleroderma?. The Journal of Rheumatology. 2001;28:1471–1473
  5. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism. 1982;25:1271–1277
  6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism. 1997;40:1725
  7. Sharp GC. Diagnostic criteria for classification of MCTD. In:  Kasukawa R,  Sharp GC editor. MCTD and Anti-Nuclear Antibodies. Amsterdam: Elsevier; 1987;p. 23–32
  8. Bohan A, Peter JB. Polymyositis and dermatomyositis. Part I. The New England Journal of Medicine. 1975;292:344–347
  9. Bohan A, Peter JB. Polymyositis and dermatomyositis. Part II. The New England Journal of Medicine. 1975;292:403–407
  10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis & Rheumatism. 1988;31:315–324
  11. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European community. Arthritis & Rheumatism. 1993;36:340–347
  12. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis. 2006;4:295–306
  13. Subcommitte for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criterion Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis & Rheumatism. 1980;23:581–590
  14. Rand Mariq H, Valter I. A working classification of scleroderma spectrum disordes: a proposal and the results of testing on a sample of patients. Clinical and Experimental Rheumatology. 2004;22(supplement 33):S5–S13
  15. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. The Journal of Rheumatology. 2001;28:1573–1576
  16. Belch JJ. Editorial. The clinical assessment of the scleroderma spectrum disorders. British Journal of Rheumatology. 1993;32:353–356
  17. Lazaro MA, Maldonado Cocco JA, Catoggio LJ, et al. Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity?. Medicine (Baltimore). 1989;68:58–65
  18. Lom-Orta H, Alarcon-Segovia D, Diaz-Jouanen E. Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis. The Journal of Rheumatology. 1980 Nov–Dec;7(6):831–837
  19. Ganczarczyk L, Urowitz MB, Gladman DD. Latent lupus. The Journal of Rheumatology. 1989;16:475–478
  20. Greer JM, Panush RS. Incomplete lupus erythematosus. Archives of Internal Medicine. 1989;149:2473–2476
  21. Alarcón GS, Williams GV, Singer JZ, et al. Early undifferentiated connective tissue disease. I. Early clinical manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. The Journal of Rheumatology. 1991;18:1332–1339
  22. Calvo-Alén J, Alarcón GS, Burgard SL, et al. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors. The Journal of Rheumatology. 1996;23:469–475
  23. Mosca M, Tavoni A, Neri R, et al. Undifferentiated connective tissue diseases: the clinical and serological profiles in 91 patients followed for at least 1 year. Lupus. 1998;7:95–100
  24. Danieli MG, Fraticelli P, Salvi A, et al. Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clinical Rheumatology. 1998;17:195–201
  25. Danieli MG, Fraticelli P, Franceschini F, et al. Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clinical and Experimental Rheumatology. 1999;17:585–591
  26. Dijkstra S, Nieuwenhuys EJ, Swaak AJ. The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterized by the presence of antinuclear antibodies (ANA). Scandinavian Journal of Rheumatology. 1999;28:33–37
  27. Williams HJ, Alarcón GS, Joks R, et al. Early undifferentiated tissue disease. VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. The Journal of Rheumatology. 1999;26:816–825
  28. Vila LM, Mayor AM, Valentin AH, et al. Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus. 2000;9:110–115
  29. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clinical and Experimental Rheumatology. 1999;17:615–620
  30. Swaak AJ, van de Brink H, Smeenk RJ, et al. Incomplete lupus erythematosus: results of a multicenter study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology. 2001;40:89–94
  31. Cavazzana I, Franceschini F, Belfiore N, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow up of 148 patients. Clinical and Experimental Rheumatology. 2001;19:403–409
  32. Bodolay E, Csiki Z, Szekanecz Z, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clinical and Experimental Rheumatology. 2003;21:313–320
  33. Mosca M, Neri R, Bencivelli W, et al. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow up of 5 years. The Journal of Rheumatology. 2002;29:2345–2349
  34. Alarcon GS, Willkens RF, Ward JR, et al. Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: follow-up analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Arthritis & Rheumatism. 1996;39:403–414
  35. Williams HJ, Alarcón GS, Neuner R, et al. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. The Journal of Rheumatology. 1998;25:261–268
  36. Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody. Annals of the Rheumatic Diseases. 1985;44:245–251
  37. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine. 2003;349:1526–1533
  38. Danieli MG, Rossetti L, Fraticelli P, et al. Autoimmune thyroid diseases in patients with undifferentiated connective tissue diseases. Clinical Rheumatology. 2000;19:42–46
  39. Mosca M, Baldini C, Bombardieri S. Undifferentiated connective tissue diseases in the 2004. Clinical and Experimental Rheumatology. 2004;22:S14–S18
  40. Clegg DO, Williams JH, Singer JZ, et al. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. The Journal of Rheumatology. 1991;18:1340–1343
  41. Belfiore N, Rossi S, Bobbio-Pallavicini F, et al. Anti-Ro(SSA) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease. Joint Bone Spine. 2000;67:183–187
  42. Mosca M, Neri R, Srigini F, et al. Pregnancy outcome in patients with undifferentiated connective tissue disease: a preliminary study on 25 pregnancies. Lupus. 2002;11:304–307
  43. Doria A, Iaccarino L, Ghirardello A, et al. Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Bechet disease. Lupus. 2004;13(9):690–695
  44. Vazquez-Del Mercado M, Martin-Marquez BT, Petri MH, et al. Molecular mechanisms in normal pregnancy and rheumatic diseases. Clinical and Experimental Rheumatology. 2006 Nov–Dec;24(6):707–712
  45. Asherson Ronald A. New subsets of the antiphospholipid syndrome in 2006: “PRE-APS” (probable APS) and microangiopathic antiphospholipid syndromes (“MAPS”). Autoimmunity Reviews. 2006;6:76–80
  46. Czirják L, Kiss CG, Lövei C, et al. Survey of Raynaud's phenomenon and systemic sclerosis based on a representative study of 10,000 South-Transdanubian Hungarian inhabitants. Clinical and Experimental Rheumatology. 2005;23:801–808
  47. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated or both?. The Journal of Rheumatology. 2005;32:213–215

PII: S1521-6942(07)00107-6

doi: 10.1016/j.berh.2007.09.004

Best Practice & Research Clinical Rheumatology
Volume 21, Issue 6 , Pages 1011-1023 , December 2007

Article Tools